| ¿µ¹® | VDRL(venereal disease research laboratory) | ÇÑ±Û | ¼ºº´ ¿¬±¸½ÇÇè½Ç |
|---|---|---|---|
| ¼³¸í | ¸Åµ¶±ÕÀÇ reagin¿¡ ´ëÇÑ Ç×ü. ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ¿Í Ä¡·áÈ¿°ú ÆÇÁ¤¿¡µµ »ç¿ëµÈ´Ù. ¸Åµ¶¿Ü¿¡µµ Àü½Å¼ºÈ«¹Ý¼º³¶Ã¢, ·ù¸¶Æ¼½º°üÀý¿° µî¿¡¼µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | amino acids | ÇÑ±Û | ¾Æ¹Ì³ë»ê |
|---|---|---|---|
| ¼³¸í | ¾Æ¹Ì³ë±â(£NH3)¿Í Ä«¸£º¹½Ç±â(£COOH)¸¦ °¡Áö°í ÀÖ´Â ¸ðµç À¯±â¹°Áú. ´Ü¹éÁúÀ» ÀÌ·ç´Â ±âº»´ÜÀ§°¡ µÈ´Ù. Áï ´Ü¹éÁúÀº ¾Æ¹Ì³ë»êÀÌ ¿¬°áµÇ¾î¼ ÀÌ·ç´Â °ÍÀÌ´Ù. ÀÎü¿¡¼´Â ¾Æ¹Ì³ë»êÀÌ ´Ü¹éÁúÀÇ ±âº»´ÜÀ§°¡ µÇ´Â °Í¿Ü¿¡ ½Å°æ¼¼Æ÷¿Í ½Å°æ¼¼Æ÷°¡ ¼·Î ¿¬¶ôÀ» ÁÖ°í ¹Þ´Âµ¥ ¾²ÀÌ´Â ½Å°æÀü´Þ¹°Áú·Î¼ÀÇ ¿ªÇÒµµ ÇÑ´Ù. »ç¶÷ÀÇ ´Ü¹éÁúÀº 20°¡ÁöÀÇ ¾Æ¹Ì³ë»êÀ¸·Î ±¸¼ºµÈ´Ù. Áï »ç¶÷¿¡ ÀÖ¾î¼ ´Ü¹éÁúÀ» ÇÕ¼ºÇÏ´Â µ¥´Â 20°¡ÁöÀÇ ¾Æ¹Ì³ë»êÀÌ ÇÊ¿äÇÏ´Ù. ¿©±â¿¡¼ 11°¡Áö´Â ÀÎü³»¿¡¼ Á÷Á¢ ÇÕ¼ºÇÒ ¼ö ÀÖÁö¸¸ ³ª¸ÓÁö 9°¡Áö´Â ÇÕ¼ºÇÒ ¼ö ¾ø°í ¹Ýµå½Ã À½½Ä¹°¿¡¼ ¼·ÃëÇØ¾ß ÇÑ´Ù. À̰ÍÀ» Çʼö¾Æ¹Ì³ë»êÀ̶ó°í ÇÑ´Ù. |
||
| ¿µ¹® | special sense | ÇÑ±Û | Ư¼ö°¨°¢ |
|---|---|---|---|
| ¼³¸í | °¨°¢À» Å©°Ô ºÐ·ùÇÒ ¶§, ü¼º°¨°¢, ³»Àå°¨°¢ ±×¸®°í Ư¼ö°¨°¢ ¼¼ °¡Áö·Î ºÐ·ùÇϰí ÀÖ´Ù. Ư¼ö°¨°¢Àº ¹Ì°¢, Èİ¢, û°¢, ½Ã°¢ÀÇ ³× °¡Áö °¨°¢ÀÇ ÃÑĪÀÌ´Ù. Ã˰¢Àº ü¼º°¨°¢¿¡ ¼ÓÇϸç, °æ¿ì¿¡ µû¶ó ÆòÇü°¨°¢À» Ư¼ö°¨°¢¿¡ ³Ö±âµµ ÇÑ´Ù. |
||
| ¿µ¹® | nucleic acid | ÇÑ±Û | ÇÙ»ê |
|---|---|---|---|
| ¼³¸í | ¿°±â, ´ç, ÀλêÀ¸·Î ÀÌ·ç¾îÁø ´ºÅ¬·¹¿ÀƼµå°¡ ±ä »ç½½ ¸ð¾çÀ¸·Î ÁßÇÕµÈ °íºÐÀÚ ¹°Áú. À¯ÀüÀ̳ª ´Ü¹éÁú ÇÕ¼ºÀ» Áö¹èÇÏ´Â Áß¿äÇÑ ¹°Áú·Î, »ý¹°ÀÇ Áõ½ÄÀ» ºñ·ÔÇÑ »ý¸í Ȱµ¿ À¯Áö¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù. ±¸¼º ´çÀÎ ¿Àź´çÀÌ ¸®º¸¿À½ºÀÎ ¸®º¸ÇÙ»ê°ú µð¿Á½Ã¸®º¸¿À½ºÀÎ µð¿Á½Ã¸®º¸ ÇÙ»êÀ¸·Î ³ª´¶´Ù. ÆæÅ佺·Î¼ ¸®º¸½º³ª µ¥¿Á½Ã¸®º¸½º ¾î´À ÇÑÂʸ¸À» Æ÷ÇÔÇϸç ÀüÀÚ¸¦ ¸®º¸ÇÙ»ê(RNA), ÈÄÀÚ¸¦ µ¥¿Á½Ã¸®º¸ÇÙ»ê(deoxyribonucleic acid, DNA)À̶ó ºÎ¸¥´Ù. ¸ðµÎ 4Á¾·ùÀÇ À¯±â¿°±â¿¡ ÀÇÇØ Ư¡Áö¾îÁö¸ç ¾Æµ¥´Ñ, ±¸¾Æ´Ñ ¹× ½ÃÅä½ÅÀº ¾çÀÚ¿¡ °øÅëÀÌ´Ù. Ƽ¹ÎÀº DNA¿¡, ¿ì¶ó½ÇÀº RNA¿¡ Æ÷ÇԵȴÙ. DNA´Â ÁÖ·Î ÇÙ¿¡ Á¸ÀçÇϸç ÇüÁúÀ¯Àü¿¡ ±×¸®°í RNA´Â ¼¼Æ÷Áú¼Ó¿¡¼ ´Ü¹éÁú ÇÕ¼º¿¡ °ü¿©ÇÑ´Ù. ¼·ÃëµÈ ÇÙ»êÀº ¼ÒȰü¿¡¼ ±¸¼ººÐÀڷαîÁö °¡¼öºÐÇØµÇ¾î Èí¼öµÈ´Ù. |
||
| DNA | Deoxyribo-Nucleic Acid |
|---|---|
| GnRH | Gonadotropin Releasing Hormone [HP 1898, 2034] = LHRH = Go... |
| mRNA | messenger Ribo-Nucleic Acid |
| RNA | Ribo-Nucleic Acid |
| VLCFA | Very Long Chain Fatty Acids |
| CSHCN | Children With Special Health Care Needs |
|---|---|
| HSS | Hospital for Special Surgery |
| NASBA | Nucleic Acid Sequence Based Amplification |
| NA | Nucleic acid |
| NAT | Nucleic acid testing |
| nucleic acids | Highly complex portions of nucleoproteins that yield a mixture of purines and pyrimidines, a ribose or deoxyribose component, and phosphoric acid on complete hydrolysis. The two general types are ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). (12 Dec 1998) |
|---|---|
| nucleic acids, nucleotides, and nucleosides | Complex compounds of high molecular weight occurring in living cells. These are basically of two types, ribonucleic (RNA) and deoxyribonucleic (DNA) acids, both of which consist of nucleotides (nucleoside phosphates linked together by phosphate bridges). (12 Dec 1998) |
| retracted publication | Designation of an article or book retracted in whole or in part by an author or authors or an authorised representative. It identifies a citation previously published and now retracted through a formal issuance from the author, publisher, or other authorised agent, and is distinguished from retraction of publication, which identifies the citation retracting the original published item. (12 Dec 1998) |
| retraction of publication | A statement issued by one or more authors of an article or a book, withdrawing or disavowing acknowledgment of their participation in performing research or writing the results of their study. In indexing, the retraction is sent to the editor of the publication in which the article appeared and is published under the rubric "retraction" or in the form of a letter. This publication type designates the author's statement of retraction: it should be differentiated from retracted publication which labels the retracted publication. (12 Dec 1998) |
| publication bias | The influence of study results on the chances of publication and the tendency of investigators, reviewers, and editors to submit or accept manuscripts for publication based on the direction or strength of the study findings. Publication bias has an impact on the interpretation of clinical trials and meta-analyses. Bias can be minimised by insistence by editors on high-quality research, thorough literature reviews, acknowledgement of conflicts of interest, modification of peer review practices, etc. (12 Dec 1998) |
| duplicate publication | Simultaneous or successive publishing of identical or near- identical material in two or more different sources without acknowledgment. It differs from reprinted publication in that a reprint cites sources. It differs from plagiarism in that duplicate publication is the product of the same authorship while plagiarism publishes a work or parts of a work of another as one's own. The designation given an article or book of identical or nearly identical material published simultaneously or successively with the material previously published elsewhere, without acknowledgment. (12 Dec 1998) |
| anniversaries and special events | Occasions to commemorate an event or occasions designated for a specific purpose. (12 Dec 1998) |
| hospitals, special | Hospitals which provide care for a single category of illness with facilities and staff directed toward a specific service. (12 Dec 1998) |
| special anatomy | The anatomy of certain definite organs or groups of organs involved in the performance of special functions; descriptive anatomy dealing with the separate systems. (05 Mar 2000) |
| special aquatic site | Those sites identified in 40 CRF 230, Subpart E (i.e., sanctuaries and refuges, wetlands, mud flats, vegetated shallows, coral reefs, and riffle and pool complexes). They are geographic areas, large or small, possessing special ecological characteristics of productivity, habitat, wildlife protection, or other important and easily disrupted ecological values. These areas are generally recognised as significantly influencing or positively contributing to the general overall environmental health or vitality of the entire ecosystem of a region. Source: Environmental Protection Agency, 40 CFR |
| special hospital | A hospital for the medical and surgical care of patients with specific types of diseases, as of the ear, nose, and throat, eyes, or mental illness. (05 Mar 2000) |
| special nurse | A nurse, who might be a registered nurse or a practical nurse, assigned to limited, specialised functions; usually synonymous with private duty nurse. (05 Mar 2000) |
| special sensation | A sensation referred to a stimulus produced by an external body and acting on any of the sense organs. Subjective sensation, a sensation not readily referrable to a denotably verifiable stimulus. (05 Mar 2000) |
| special sense | One of the five senses related respectively to the organs of sight, hearing, smell, taste, and touch. (05 Mar 2000) |
| special somatic afferent column | A column of gray matter in the hindbrain of the embryo, represented in the adult by the nuclei of the auditory and vestibular nerves. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|